Key terms > Contact us > Career opportunities > For the media > Corporate collaborations > Search > Home  
        McGovern Institute for Brain Research at MIT
impact

new funding for new knowledge

opportunities

ease

leadership board

become a friend of the institute




The new McGovern Leadership Board complements the Institute's prestigious Board of Directors and Scientific Advisory Board and plays a critical role in the Institute and its research progress.

The mission of the Leadership Board is to provide counsel and advice, to serve as educated ambassadors beyond the academic community, and to help provide and secure the financial resources that support and enhance the mission of the McGovern Institute. Comprised of distinguished and influential individuals from diverse fields and backgrounds, members share with the Institute their financial support, as well as their talents in science, business finance, education, communication and other important areas of expertise and experience.

I'd like to learn more.

Leadership Board

  • James Poitras, Board Chairman, President and CEO, Highland Laboratories, Inc.
  • Tenley E. Albright, M.D., Director, Collaborative Initiatives at MIT
  • Gerald Burnett, Ph.D., CEO, Avistar Communications Corporation
  • Robert M. Buxton, Executive Vice President Peter Kimmelman Asset Management LLC
  • Eric Cosman, Ph.D., President, Cosman Company Inc.
  • Nicholas Covatta, Chairman, Atlantis Group Inc.
  • Mark Gorenberg, Partner, Hummer Winblad Venture Partners
  • Perry Ha, Managing Director, Athena Technology Ventures
  • Kenneth Kaplan, Associate Director, Urban Design Laboratory Earth Institute, Columbia University
  • Zack Lynch, Managing Director, NeuroInsights
  • Robert Metcalfe, Ph.D., General Partner, Polaris Venture Partners
  • Jane Pauley, Broadcast Journalist, Author
  • Thomas F. Peterson, Jr., Inventor, Entrepreneur, Philanthropist
  • Patricia Poitras, President, Poitras Charitable Foundation, Inc.
  • Sheldon Razin, Chairman of the Board, Quality Systems, Inc.
  • David W. Summa, President and CEO, Acumen Pharmaceuticals
  • Nancy Wexler, Ph.D., President, Hereditary Disease Foundation and Higgins Professor of Neuropsychology, Columbia University
   


© 2003 - 2008 McGovern Institute
Building 46-3160, MIT, Cambridge, MA 02139 617.324.0639 mcgovern@mit.edu
Site concept and design by Sametz Blackstone Associates